Question 1

Does Macquarie Group own KPTI stock?

Accepted Answer

As of its Q4 2024 13F, Macquarie Group held 500,000 shares of KPTI (Karyopharm Therapeutics), worth $338,000.

Question 2

How many shares of KPTI does Macquarie Group own?

Accepted Answer

As of its Q4 2024 13F, Macquarie Group held 500,000 shares of KPTI (Karyopharm Therapeutics).

Question 3

What is Macquarie Group's KPTI position worth?

Accepted Answer

As of its Q4 2024 13F, Macquarie Group's KPTI position was worth $338,000.

Question 4

When did Macquarie Group first buy KPTI?

Accepted Answer

Macquarie Group already held KPTI in its Q4 2018 13F, the earliest on record, and listed it in 25 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price
2025-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$3.74
2024-Q4	Unchanged	500,000	0.0%	$338,000	0.0%	$10.14
2024-Q3	Decreased	500,000	-1.1%	$415,000	0.0%	$12.45